Identiv, Inc. (INVE) Earnings Call Transcript & Summary

Thanks, operator, and I appreciate everyone being on the line for our Q1 2026 earnings conference call. I'll start by covering a handful of first-quarter highlights, since we keep building solid momentum as we carry out our Perform, Accelerate and Transform strategy. On the previous call, we mentioned reaching a major milestone: we signed a long-term deal with IFCO under which we exclusively provide BLE smart labels for their pool of reusable plastic containers, which numbers more than 400 million. Since that time, our attention has been on development work, and soon we expect to start producing more than 0.5 million pilot units, with mass production projected to kick off in Q4 of this year. We also moved the needle at our manufacturing site in Thailand, which has now completely shifted over from Singapore. That site is boosting our capacity to serve customers more efficiently and at reduced costs, all while keeping product quality and service at a high standard, which shows up in the favorable comments we hear from customers. Beyond that, we keep expanding our opportunity pipeline, especially for ID Blue, our lineup of BLE smart labels aimed at asset tracking and logistics uses. Interest is strong and rising across a number of sectors, among them global logistics, pharmaceuticals and food distributors, and we still expect to bring these products to market commercially later this year. Now to our Q1 financial results. I'm happy to say first-quarter sales came to $7.4 million, above our guidance, while other key financial metrics landed where we expected. As we had anticipated, gross margin dipped slightly compared with Q4 because of product mix along with some extra scale-up costs tied to a new customer. We look for margin to improve somewhat over the course of the year as our operations gain efficiency, though we'll face some offsetting costs in the back half from scaling up IFCO. We're beginning to feel some effects from today's macroeconomic conditions, mostly in our consumer-facing applications, where demand for higher-end products has weakened. Meanwhile, some suppliers have raised prices; we're evaluating the situation and will take pricing steps to counter those costs, while staying focused on delivering value to our customers and preserving our margin profile. Our CFO, Ed Kirnbauer, is going to walk through our Q1 financial performance in detail. After that, I'll say more about how we're progressing on our strategic initiatives.

Appreciate that, Kirsten. For Q1 of 2026, revenue came in at $7.4 million, beating the guidance range we had announced earlier, versus $5.3 million in Q1 2025. That year-over-year gain matched what we anticipated, driven by solid demand from existing clients, new customer conversions, and the advantage of a larger customer placing its entire 2026 sales volume order during Q1. GAAP gross margin for the first quarter was 17.4%, while non-GAAP came in at 23.8%, up against GAAP and non-GAAP gross margins of 2.5% and 10.8%, respectively, in Q1 2025. The main driver behind the gross margin gain was shifting production into our cutting-edge facility in Thailand; that brought procurement and production cost savings and efficiencies, better facility utilization, and removal of manufacturing production costs tied to our Singapore operation in Q1 of 2025. Beyond that, the year-over-year gross margin gain also captured the benefit from charges booked in Q1 of 2025 to cost of revenue tied to a write-down of obsolete inventory at our Singapore facility totaling $0.3 million, plus a warranty claim from one customer amounting to $0.2 million. GAAP and non-GAAP operating expenses for Q1 2026, covering research and development, sales and marketing, general and administrative, and restructuring and severance, came to $5.5 million and $4.4 million, respectively, versus $5.6 million and $4.5 million, respectively, in Q1 2025. The decline in GAAP operating expenses year over year stemmed mainly from reduced restructuring and severance expenses, partly offset by higher strategic review-related costs incurred during Q1 of 2026 relative to the first quarter of 2025. Non-GAAP operating expenses in Q1 2026 landed comparable to the prior year period, showing our ongoing disciplined allocation of operating expenses as we carry out our PAT strategic initiatives. GAAP net loss for the first quarter was $3.4 million, or $0.15 per basic and diluted share, against a GAAP net loss of $4.8 million, or $0.21 per basic and diluted share, in the first quarter of 2025. That narrower net loss came primarily from higher sales volume in Q1 2026, reduced restructuring and severance costs, and, as noted, the impact of roughly $0.5 million in charges to cost of revenue during the first quarter of 2025. Non-GAAP adjusted EBITDA loss for Q1 2026 was $2.7 million, compared with $3.9 million in the first quarter of 2025. As noted, the smaller loss resulted from production efficiencies realized at our Thailand facility, the charges to cost of revenue in Q1 of 2025, and disciplined operating expense spending as we keep executing on our PAT strategic initiatives; in the appendix of today's presentation, we've included a full reconciliation of GAAP to non-GAAP financial information, which also appears in our earnings release. Turning to the balance sheet now. We closed Q1 2026 with $124.8 million in cash, cash equivalents and restricted cash. Our balance sheet remains in a strong position, with working capital at the end of Q1 of $129.6 million. When we file our 10-Q, a complete reconciliation covering cash flows for the year to date will be included. To make things thorough, the entire balance sheet appears in the appendix to today's earnings release. Last, let me turn to how we see the second quarter of 2026 financially; we're expecting sales between $5.4 million and $6.0 million. As we've said, Q1 sales showed robust growth, partly because a sizable full year 2026 customer order came in early so product availability would be secured. Because of that, guidance for Q2 accounts for that volume having been pulled forward into Q1. On top of that, the forecast bakes in a degree of uncertainty tied to demand trends that are softening among some consumer-facing customers. As was noted on our March call, we do anticipate margin gains across 2026 as operations grow more efficient; even so, we expect gross margins to vary somewhat while we keep scaling production for the IFCO program, which is simply the usual pattern when production ramps for large programs. Once more, it's worth stressing that the cost structure gains achieved through our manufacturing transition are still intact. As these programs and volumes mature and scale, we think they underpin appealing margin results over the long term. When it comes to cash usage, we still anticipate deploying $14 million to $16 million during 2026, leaving out costs tied to the strategic review. That figure covers the cash needed for ongoing operations, plus $3.5 million in capital expenditures mostly tied to IFCO production, a $1 million working capital increase to support growth, and $1.5 million for purchasing chips, locking in favorable pricing required to fulfill customer orders, which extend past 2026. That wraps up the financial discussion. I'll now hand the call back to Kirsten.

Thanks, Ed. I'm happy with how far we've come, though I know there's still work to do before we hit our financial targets. What we're doing is producing results as we keep carrying out our Perform, Accelerate and Transform strategy. Under Perform, we're concentrating on reinforcing and expanding our core business, while also pushing operational efficiency and margin growth so that we create lasting value for shareholders and customers alike. As we talked about before, the 2-year shift of manufacturing to our Thailand facility is now officially finished. That lets us get products to customers more quickly, bring costs down, boost efficiency and widen margins. In the time since our previous discussion, the team at our Thailand site has kept moving forward well when it comes to preparing staff to work both safely and productively, all while upholding the rigorous production standards we've set. Early in the year, we rolled out fresh CRM and MRP enterprise platforms so that sales, demand planning, and operations could be tied together more effectively. On top of that, we've brought in sales and operations planning that runs each quarter, which lets our commercial side and supply chain group work from one shared demand plan and follow a strict approach to executing production. Simply put, the new systems improve our ability to react to customer requirements — faster and more accurately — and they give us clearer insight into both operations and inventory. Our commitment to establishing and maintaining strong customer ties remains, and the gains we're observing are heartening. In Q1, two among our three biggest customers renewed their supply contracts, reflecting their trust in our performance and service. Broadly speaking, the enhancements we continue to deliver, along with our focus on operational excellence, are getting a positive reception from customers. On the marketing side, our goal is for customers, prospects, and channel partners to fully understand the breadth of what we offer and what we can do, along with how we assist in tackling key business problems. To back that up, we rolled out a redesigned corporate site built to deliver straightforward, easy-to-find details on products, insights into applications, case studies, and a beefed-up Investor Relations area. From the time we went live in January, we've kept seeing more traffic to the site, higher click-through rates, and a rising volume of inquiries coming through the contact form on our website. Additionally, we keep reinforcing Identiv's standing as a thought leader, thanks to 20 articles we've published that address subjects of significance for our customers within the industry — among them, the way NFC is bringing back consumer confidence, the increasing intelligence of clinical trials, plus supply chains and AI. We took part in an AIPIA connected packaging webinar, which brought together 8 subject matter experts and centered on smart packaging trends that are fueling demand for IoT technologies. Now let's turn to our Accelerate pillar. What we're concentrating on there is generating growth within high-value segments by means of innovation, especially when it comes to BLE technology and sophisticated multicomponent manufacturing. Our strategic long-term alliance with IFCO has us very enthusiastic, and on both the product side and manufacturing side, our team is advancing well. To accommodate the specialized production equipment needed for this next-generation BLE label, renovations at the production site are nearly complete. As previously stated, we expect to begin turning out more than 0.5 million pilot units shortly, while full-scale manufacturing is scheduled for the fourth quarter. Progress on ID Blue, our exclusive BLE smart label range, is also going smoothly. There is substantial early interest in these products, which target logistics, cold chain, and asset tracking applications. We remain on track to launch this lineup before the year ends. We also wrapped up the BLE ambientChat.ai demo that we discussed on our previous call; it illustrated what physical AI could do, showing how connected items can link the physical and digital realms to provide real-time intelligent insights. Outside recognition for our innovation work keeps growing. In the quarter, we received the IoT Connected Retail Application of the Year Award as part of the 10th Annual IoT Breakthrough Awards program, which highlights how strong our technology and market position are. On a wider scale, our innovation pipeline is producing concrete outcomes. Back in April, we introduced an expanded set of ID-Safe inlays. These let you authenticate products, spot tampering, and trace items from start to finish in plenty of industries — pharma, health care, retail, food and beverage, electronics, and smart packaging among them. Demand continues to climb for ways to confirm that a product is genuine, that its packaging hasn't been messed with, and to keep an eye on it through its entire life cycle — and our ID-Safe lineup handles all of that. You can find the April 20 press release about our ID-Safe innate portfolio on our website. Turning now to pillar three, Transform. With this one, the focus is expanding the business through strategic M&A, which accelerates our path to EBITDA breakeven while also broadening what we offer and strengthening our technical capabilities. Management is continuing to work hand in hand with Raymond James, our financial adviser, as well as the lawyers advising us, on possible strategic alternatives. Ahead of turning things over for questions and answers, I'd like to update all of you on the reporting metrics we introduced during 2025, along with our quarter 1 results. To begin, the new metric covering sales pipeline and conversion tracks prospects involving either brand-new accounts or ones we hadn't done business with for over 2 years. In 2026, we're targeting a pipeline of 125 opportunities and want a minimum of 35 of them converted into sales before the year is out; we finished last year having reached 101 opportunities. When quarter one ended, the number of opportunities in our pipeline had grown to 124, and 8 of those turned into sales over the course of that quarter. Turning to another measure, we track new product development by counting the NPD initiatives currently underway; work of this kind involves building entirely new tags, inlays, or labels using RFID or BLE technology. As quarter one came to a close, 18 active NPD projects were ongoing, and 3 of them were brought to successful completion within the quarter, each sitting in a high-value segment such as cold chain or consumable authentication. A further metric, our NPD completion rate, keeps tabs on the number of projects handed off during the period. Looking ahead to 2026, our target is 7 projects finished by the time the year ends. Three projects wrapped up during Q1, which puts us in a solid position to hit that target. Looking at our current situation, we're making progress on the measurements that count most for us, and that favorable trend continues throughout the business. I'm looking forward to telling you more about how we'll maintain our execution momentum as the year progresses. Our mission remains exactly what it has always been: providing digital identities for billions of fiscal objects, delivering real-time intelligence to the world's most demanding industries. My gratitude goes out to all our employees, customers, partners and shareholders for their continued support of Identiv; with that said, I'd like to hand the call over now so we can take your questions. Operator, please open the question queue.

Actually, there are three things I want to ask. Kirsten, the first two are directed at you. Of the opportunities out there, what share is tied to health care, or is there anything else you can share regarding the remaining sectors? I believe you've provided that kind of detail before. Also, Kirsten, given IFCO and how you're positioning yourselves for a significant ramp in Q4, do you have the capacity in place to manage whatever new requests might come from new customers who come on board late in the year?

Yes. Well, thank you. That's a good question. Let me begin with the health care piece. We're tracking two separate pipelines. The first is our NPD pipeline — that's our new product development pipeline. Within it, approximately one-third of the projects are connected to health care. Then, shifting to the new opportunity pipeline, which blends some new product development with more chances for standard product, or a product needing only minor customization — I'd characterize that as somewhat lower when it comes to the health care share. It's likely closer to 20% health care. So broadly speaking, when we take a wide view of our opportunities, I'd say roughly one-quarter of them, across both the NPD pipeline and the sales opportunity pipeline, involve health care. Now, regarding your second question... Apologies, please continue.

On the resources question — when you're ramping up IFCO, do you have enough to take on new customers?

Yes. Clearly, IFCO is a huge program. Right now it's consuming a considerable share of our engineering capacity while we lock down the design and nail down the manufacturing process. But once that work moves through the coming couple of quarters and we finish the product spec and the product design, engineering will free up and gain somewhat more bandwidth to pick up additional projects. And honestly, by the time we reach the fourth quarter, the focus shifts more toward manufacturing; so naturally, we'll bring people on board — operators specifically — to run the production equipment. Yet apart from bringing on new operators to run the production equipment, from an engineering standpoint we genuinely already have every resource we need in-house at this point.

Understood. If I may, I'd like to ask about gross margins. What range are you anticipating for Q2, and what do you expect for Q3 and Q4?

Sure. Thanks. Regarding that — our practice is not to provide guidance beyond one quarter ahead. What I can tell you, though, is that sales came in strong this quarter. We benefited from a pull forward involving a customer who placed an order for the entire year's supply during the first quarter. From a margin standpoint, though, my expectation is that margins will keep improving within our core business and among our core customers, thanks to all the advantages we're gaining from the Thailand transition and other items. So I'd anticipate margins will go on improving. That said, we're scaling up for the IFCO project; therefore I'd expect — we certainly will expect some of those gains to be offset as we head into the next quarter and the remainder of the year too.

Kirsten, I'd like to begin with a point of clarification. We understood the first quarter would carry an advantage, since material bought then would be consumed across the year, yet that factor, or perhaps another one, appeared somewhat larger than what I had anticipated. Could you revisit Q1 and explain what made revenues come in a bit stronger than many of us had assumed?

Yes. Sure. We felt good about our first-quarter sales. As we noted earlier and guided on during the prior quarter, one advantage came from a bigger customer who bought its entire year's worth during Q1. Beyond that, we simply witnessed solid demand overall as the year began. A number of our customers submitted orders somewhat above their forecasts, which pleased us. That said, we're now noticing some softening tied to certain global economic conditions currently at play. Things kicked off with some encouraging orders arriving in Q1, but we're detecting a possible deceleration in the back half, particularly among certain customers who face consumers.

And regarding that, Kirsten, since I was about to ask the same thing next, does it vary by region? Or does it show up in any specific area among the businesses that face consumers? Please give us a sense of how widely this is being seen across those consumer-facing operations.